Age, Blasts, performance status and lenalidomide therapy influence the outcome of myelodysplastic syndrome with isolated del(5q): a study of 58 South American patients (2022)
- Authors:
- USP affiliated authors: AZEVEDO NETO, RAYMUNDO SOARES DE - FM ; ROCHA, VANDERSON GERALDO - FM ; VELLOSO, ELVIRA DEOLINDA RODRIGUES PEREIRA - FM
- Unidade: FM
- DOI: 10.1016/j.clml.2021.07.026
- Subjects: DOENÇAS HEMATOLÓGICAS; SOBREVIDA; NORTE-AMERICANOS
- Agências de fomento:
- Cytogenetics and Pathological Anatomy Laboratories Hospital das Clinicas da Faculdade de Medicina da USP
- Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)ANPCyT
- Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical lymphoma myeloma & leukemia
- ISSN: 2152-2650
- Volume/Número/Paginação/Ano: v. 22, n. 1, p. E1-E6, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
AZEVEDO NETO, Raymundo Soares de et al. Age, Blasts, performance status and lenalidomide therapy influence the outcome of myelodysplastic syndrome with isolated del(5q): a study of 58 South American patients. Clinical lymphoma myeloma & leukemia, v. 22, n. 1, p. E1-E6, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clml.2021.07.026. Acesso em: 17 out. 2024. -
APA
Azevedo Neto, R. S. de, Belli, C., Bassolli, L., Ferri, L., Perusini, M. A., Enrico, A., et al. (2022). Age, Blasts, performance status and lenalidomide therapy influence the outcome of myelodysplastic syndrome with isolated del(5q): a study of 58 South American patients. Clinical lymphoma myeloma & leukemia, 22( 1), E1-E6. doi:10.1016/j.clml.2021.07.026 -
NLM
Azevedo Neto RS de, Belli C, Bassolli L, Ferri L, Perusini MA, Enrico A, Pereira TDM, Junior WFS, Rocha VG, Velloso EDRP. Age, Blasts, performance status and lenalidomide therapy influence the outcome of myelodysplastic syndrome with isolated del(5q): a study of 58 South American patients [Internet]. Clinical lymphoma myeloma & leukemia. 2022 ; 22( 1): E1-E6.[citado 2024 out. 17 ] Available from: https://doi.org/10.1016/j.clml.2021.07.026 -
Vancouver
Azevedo Neto RS de, Belli C, Bassolli L, Ferri L, Perusini MA, Enrico A, Pereira TDM, Junior WFS, Rocha VG, Velloso EDRP. Age, Blasts, performance status and lenalidomide therapy influence the outcome of myelodysplastic syndrome with isolated del(5q): a study of 58 South American patients [Internet]. Clinical lymphoma myeloma & leukemia. 2022 ; 22( 1): E1-E6.[citado 2024 out. 17 ] Available from: https://doi.org/10.1016/j.clml.2021.07.026 - Clinical impact of dysplastic changes in acquired aplastic anemia: a systematic study of bone marrow biopsies in children and adults
- Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia
- Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience
- Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen
- High proliferative index in acquired aplastic anemia (AAA) bone marrow does not predict progression to myelodusplastic syndromes (MDS)
- High Proliferative Index in Acquired Aplastic Anemia (AAA) Bone Marrow Does Not Predict Progression to Myelodysplastic Syndromes (MDS)
- Outcomes and second neoplasms in hairy cell leukemia: a retrospective cohort
- Morphological, immunohistochemical and cytogenetic bone marrow characterization of 12 patients with acquired aplastic anemia (AAA) that progressed to myelodysplastic syndromes (MDA)
- Morphological, Immunohistochemical and Cytogenetic Bone Marrow Characterization of 12 Patients with Acquired Aplastic Anemia (AAA) That Progressed to Myelodysplastic Syndromes (MDS)
- Adult acute lymphoblastic leukemia in a resource-constrained setting: outcomes after expansion of genetic evaluation
Informações sobre o DOI: 10.1016/j.clml.2021.07.026 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
